Renapharma AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1999, the company has 4 employees and reported revenue of SEK 35.6m in its latest annual filing.
In its most recent annual report (2024), Renapharma AB reported revenue of SEK 35.6m, an increase of 18% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of SEK 4.1m, and the EBITDA margin stood at 22.1%.
At the end of 2024, equity financed 74.1% of the balance sheet, and current assets covered short-term debt 4.6 times.
Frequently asked questions
What is the Org number of Renapharma AB?
Renapharma AB is registered with Bolagsverket / SCB under Org 5565718946.
What is the revenue of Renapharma AB?
Renapharma AB reported revenue of SEK 35.6m in 2024.
How many employees does Renapharma AB have?
Renapharma AB employs 4 people as of the latest annual report.
Who is the CEO of Renapharma AB?
Urban Håkan Widén is the CEO of Renapharma AB, in role since 2025.
Who is the chairman of Renapharma AB?
Jan Gustaf Zetterberg chairs the board of Renapharma AB, in role since 2025.
Where is Renapharma AB headquartered?
Renapharma AB's registered address is Riddargatan 16 2tr.
